abstract |
The present invention relates to compounds of formula (I) and salts thereof, as well as compositions and uses thereof, wherein: R 1 -R 4 has any value defined in the specification. The compounds are useful as inhibitors of BRG1, BRM and/or PB1. The present invention also includes a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and a method for using the above-mentioned compound and salt to treat various BRG1-mediated disorders, BRM-mediated disorders and/or PB1-mediated disorders method. |